Solventum Corporation (SOLV) Free Cash Flow (FCF): $-203.00M
The free cash flow (FCF) for Solventum Corporation (SOLV) is $-203.00M. It is below its 12-month average by 151.07% ($397.50M).
SOLV Free Cash Flow (FCF) Chart
SOLV Average Free Cash Flow (FCF) Chart
SOLV Current vs Average Free Cash Flow (FCF) Chart
SOLV Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$-203.00M
FREE CASH FLOW (FCF) AVG TTM
$397.50M
FREE CASH FLOW (FCF) AVG 3Y
$962.00M
FREE CASH FLOW (FCF) AVG 5Y
$1.25B
FREE CASH FLOW (FCF) AVG 10Y
$1.25B
FREE CASH FLOW (FCF) AVG 15Y
$1.25B
FREE CASH FLOW (FCF) AVG 20Y
$1.25B
CURRENT VS TTM AVG
-151.07%
CURRENT VS 3Y AVG
-121.10%
CURRENT VS 5Y AVG
-116.18%
CURRENT VS 10Y AVG
-116.18%
CURRENT VS 15Y AVG
-116.18%
CURRENT VS 20Y AVG
-116.18%
FCF Analysis
Free Cash Flow (TTM)
$-203.00M
FCF Yield
N/A
Price/FCF
N/A
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Solventum Corporation Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Solventum Corporation (SOLV)?
- The free cash flow (FCF) for SOLV stock is $-203.00M.
- What is the TTM average free cash flow (FCF) for Solventum Corporation (SOLV)?
- The TTM average free cash flow (FCF) for SOLV stock is $397.50M.
- What is the 3Y average free cash flow (FCF) for Solventum Corporation (SOLV)?
- The 3Y average free cash flow (FCF) for SOLV stock is $962.00M.
- What is the 5Y average free cash flow (FCF) for Solventum Corporation (SOLV)?
- The 5Y average free cash flow (FCF) for SOLV stock is $1.25B.
- What is the 10Y average free cash flow (FCF) for Solventum Corporation (SOLV)?
- The 10Y average free cash flow (FCF) for SOLV stock is $1.25B.
- What is the 15Y average free cash flow (FCF) for Solventum Corporation (SOLV)?
- The 15Y average free cash flow (FCF) for SOLV stock is $1.25B.
- What is the 20Y average free cash flow (FCF) for Solventum Corporation (SOLV)?
- The 20Y average free cash flow (FCF) for SOLV stock is $1.25B.
Solventum Corporation Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-12-31 | $-10.00M |
| 2024-12-31 | $805.00M |
| 2023-12-31 | $1.63B |
| 2022-12-31 | $1.43B |
| 2021-12-31 | $1.93B |
| 2020-12-31 | $1.75B |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson